
Stock Trend Analysis Report
Prepared for you on Monday, September 8, 2025.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Long-Term Uptrend (+90) - ALNY is in a strong uptrend that is likely to continue. While ALNY is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid ALNY?
MarketClub looks at technical strength and momentum to determine if the timing is right for ALNY.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for ALNY
The long-term trend has been UP since May 30th, 2025 at 300.9000
The intermediate-term trend has been UP since Apr 28th, 2025 at 253.2500
The short-term trend has been UP since Sep 4th, 2025 at 456.1804
Smart Scan Analysis for ALNY
Based on our trend formula, ALNY is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
457.310 | 463.000 | 452.845 | 454.885 | +2.885 |
Prev. Close | Volume | Bid | Ask | Time |
452.000 | 747759 | 2025-09-08 15:59:39 |
Year High | 153.985 | Year High Date | 2018-03-20 |
Year Low | 63.57 | Year Low Date | 2018-11-15 |
52wk High | 469.81 | 52wk High Date | 2025-08-22 |
52wk Low | 205.87 | 52wk Low Date | 2025-04-09 |
Year End Close | 18.25 | Average Volume | 1,102,882 |
Shares Outstanding | 131,079 | Short Interest | 3,831,176 |
% Institutional | 73.7 | Market Cap | 9,582M |
Assets | 456,601,900M | Liabilities | 431,542,800M |
P/E Ratio | -22.21630000 | Beta | 1.71 |
Volatility | 72.13 |